NEW YORK (GenomeWeb) — The US Securities and Exchange Commission today charged Bruker with violating the Foreign Corrupt Practices Act.

The SEC charged that the Billerica, Mass.-based company provided non-business related travel and improper payments to Chinese government officials in an effort to win business.

Bruker has agreed to pay approximately $2.4 million to settle the charges, including $1,714,852 in disgorgement, $310,117 in prejudgment interest, and a $375,000 penalty.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.